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Dear Readers,
Welcome to the third issue of Transformative Medicine. This quarter we are introducing two new regular sections
to the journal: Updates in Pharmacology and Updates and Controversies in Family Practice.
We understand the time constraints on practicing physicians and advanced practice providers in keeping abreast of
recent pharmacologic approvals and new clinical guidelines. It is our goal to disseminate clinically relevant information to the busy clinician.
To that end, this quarter’s issue has information on four novel drugs that have a high likelihood of being encountered in the outpatient practice. Although some of these drugs may be prescribed by specialist, it is important to
understand the mechanism of action and anticipated adverse events for these medications. This issue introduces the
reader to novel medications for the treatment of heart failure, HIV, unresponsive hypercholesterolemia, and H. pylori.
We are also proud to introduce Updates and Controversies in Family Practice. This quarter we focus on the latest
guidelines for the diagnosis and management of Chlamydia and Gonorrhea infections. This update is based on the
2021 United States Preventive Service Task Force and the Centers for Disease Control guidelines. The article includes
recommendations for follow up testing.
These new sections join ECG of the Quarter introduced in the last issue. Our goal is to review common presentation with classic electrocardiogram findings often seen in clinical practice. In addition to reviewing the ECG pattern,
the review offers recommendations for further diagnostic evaluation and specialty referral considerations.
Transformative Medicine welcomes reader feedback on these new sections as well ideas on other sections that
would be helpful to the practicing clinician.
Finally, we welcome all researchers to submit their work to Transformative Medicine as we grow.
Regards,
Adam Sigal, MD
Editor-in-Chief
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